Task order no. 4 - rosenzweig-lipson - mscp - LO
Ended Awarded Last action
- Contract number
- 75N95018F00004
- Awardee
-
Curia Global Inc. UEI ELCNZCS8GEA3
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,376,050
Award facts
- Opportunity
-
- NIHNINDS1701 Solicitation number
- Medicinal Chemistry Support Program for Therapeutic Development (MCSP) Award Notice · Posted Mar 19, 2018
- Medicinal Chemistry Support Program for Therapeutic Development (MCSP) Award Notice · Posted Jun 30, 2017
- Contract value 100% obligated
- $1,376,049.53 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Institute on Aging National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Albany, NY 12212, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$12,887 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $1,388,937 |
About this award
This federal contract task order was awarded by the U.S. Department of Health and Human Services' National Institutes of Health (NIH) National Institute on Aging to Curia Global Inc., doing business as Amri, a leading global contract development and manufacturing organization (CDMO). The $1,376,049.53 cost-plus-fixed-fee task order, awarded on August 15, 2018, supports the Medicinal Chemistry Support Program for Therapeutic Development, providing chemistry, manufacturing, and controls development services, exploratory chemistry, and other pharmaceutical research and development support. The work, performed in Albany, NY, is not associated with a set-aside program. Curia has provided similar services to other NIH entities, supporting initiatives in areas such as Alzheimer's disease, Parkinson's disease, pain, stroke, substance abuse, and infectious diseases.
Quick answers
Who was awarded contract 75N95018F00004?
75N95018F00004 was awarded to Curia Global Inc. by National Institute on Drug Abuse (National Institutes of Health) on August 15, 2018.
How much is contract 75N95018F00004 worth?
The government has obligated $1,376,050 on 75N95018F00004.
Which agency awarded contract 75N95018F00004?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95018F00004, with funding from National Institute on Aging (National Institutes of Health).
Is contract 75N95018F00004 an order under another contract?
Yes. 75N95018F00004 is a delivery order under HHSN271201800001I, an indefinite delivery contract.
Was contract 75N95018F00004 competed?
The extent of competition for 75N95018F00004 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award